Holman: Follow-on Biologics Bill Threatens Innovation By Weakening Patent Rights

Holman: Follow-on Biologics Bill Threatens Innovation By Weakening Patent Rights

Chris Holman, Professor at the University of Missouri-Kansas City School of Law and author of Holman’s Biotech IP Blog, recently posted a great summary of the patent provisions in the follow-on biologics bill currently under consideration in Congress.

You can read Holman’s post here.

Filed under: Patently BIOtech,